https://sciex.com/content/SCIEX/na/us/en


Glyphosate, a Polar Pest Put to Test

Jun 20, 2016 | Blogs, Environmental / Industrial, Food / Beverage | 0 comments

No other pesticide has courted more media attention and controversy in recent months than glyphosate, with governments and national agencies debating its use and health effects. The following links just show some of the media attention this organophosphorus compound has received:

Download Presentation >

However irrespective of whether it poses a risk or not the analysis of glyphosate and other polar compounds in food and beverage products has been a challenge. Attaining the required sensitivity, dealing with complex matrices and sample prep can put a serious strain and demand on your laboratory. A common practice for the analysis of glyphosate and the other associated polar compounds such as AMPA, Glufosinate, and MMPA is to derivatize the samples during the preparation.

The derivatization method may be effective however there is a serious efficiency problem associated with it, the time it takes the analysts to prep and extract the sample. Derivatization can be a time-consuming procedure and can, therefore, affect a lab’s productivity, turnaround, and margins.

In a recent presentation, on the QTRAP® 6500+ System, we conducted an in-depth evaluation into the Quantitation of Underivatized Glyphosate and Other Polar Pesticides. This comprehensive study details the various techniques and LC conditions that we tested on a variety of matrices.  In this study, we show how the SelexION® reduces interferences and can meet your required levels of sensitivity.

 

Questions and answers to help improve your mycotoxin analysis

During a recent webinar I shared method details for mycotoxin analysis on the SCIEX 7500 system. In this blog i will share the Q&A for the submitted questions that we did not have chance to answer during the live webinar.

A 2-fold revolution: MS approaches for the bioanalysis of oligonucleotide therapeutics

In 1998, the US Food and Drug Administration (FDA) approved fomivirsen as the first therapeutic oligonucleotide therapeutic. This approval marked a revolution of mechanism of action discovered decades before finally coming to fruition. Since then, the landscape of chemical modifications of oligonucleotides, conjugations and formulations has evolved tremendously, contributing to improvements in stability, efficacy and safety. Today, more than a dozen antisense oligonucleotides (ASOs) and small interfering RNA (siRNA) drugs are on the market, most of which are designated as orphan drugs for treating rare genetic diseases.

Is “right first time, every time” a pipedream for metabolite identification by LC-MS?

If we lived in an ideal world, it would be possible to unambiguously identify metabolites using a single analytical experiment. This analytical technique would need to be efficient and easily generate the information needed from a routine assay that is also robust, enabling confident decision-making during drug discovery.

Posted by

0 Comments

Submit a Comment

Wordpress Social Share Plugin powered by Ultimatelysocial